Literature DB >> 24005190

Lower extremity amputations: factors associated with mortality or contralateral amputation.

Samir K Shah1, James F Bena, Matthew T Allemang, Rebecca Kelso, Daniel G Clair, Lina Vargas, Vikram S Kashyap.   

Abstract

BACKGROUND: Tissue loss or gangrene in the setting of lower extremity peripheral artery disease (PAD) may result in amputation. Previous studies have demonstrated elevated mortality rates after major transtibial and transfemoral amputation. Also, amputation of 1 leg may be associated with subsequent major amputation of the contralateral leg. The aim of our study was to identify patient variables associated with mortality and contralateral amputation.
METHODS: We reviewed the medical records of patients who underwent transfemoral or transtibial amputation secondary to PAD from 2004 to 2009. A total of 454 consecutive major amputations were performed on 391 patients, with 63 of these having a subsequent contralateral amputation. Standard demographic information, comorbidities, prior vascular interventions, and relevant procedural information were extracted from patient records. Kaplan-Meier estimates of survival were calculated. Cox proportional hazard models were used to estimate the risk of death and contralateral amputation. Multivariate Cox proportional hazards models were fit for all variables shown to be marginally associated in the univariate model.
RESULTS: In 391 amputees, the mean age was 67.3 years, 63% were male and 62% were caucasian. Patients had high rates of diabetes (63%), hypertension (83%), renal insufficiency (35%), hyperlipidemia (51%), and prior ipsilateral vascular intervention (75%). Seventy percent of patients had below-knee amputations. Perioperative mortality was 9.2% (n = 36). Survival at 12 and 24 months was 70% (95% confidence interval [CI], 65%-74%) and 60% (95% CI, 55%-65%), respectively. Multivariate analysis demonstrated that several independent factors were detrimental to survival including chronic obstructive pulmonary disease (hazard ratio [HR] 1.82, P = .002), dialysis dependence (HR 2.50, P < .001), high cardiac risk (HR 2.20, P < .001), and guillotine amputation (HR 2.49, P = .004). Dialysis (HR 2.42, P = .002) and revision of the index ipsilateral amputation to a higher level (HR 2.02, P = .014) were associated with a subsequent contralateral amputation.
CONCLUSIONS: Patients with advanced PAD that require lower extremity amputation have diminished survival and significant contralateral amputation rates. Elderly patients on dialysis are particularly prone to dying or losing the other leg after a major amputation. These data support strategies to enhance limb preservation and optimize medical comorbidities in these patients.

Entities:  

Keywords:  contralateral amputation; major amputation; mortality

Mesh:

Year:  2013        PMID: 24005190     DOI: 10.1177/1538574413503715

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  13 in total

1.  Risk of lower limb amputation in a national prevalent cohort of patients with diabetes.

Authors:  Jason K Gurney; James Stanley; Steve York; Dieter Rosenbaum; Diana Sarfati
Journal:  Diabetologia       Date:  2017-11-03       Impact factor: 10.122

2.  An enhanced treatment program with markedly reduced mortality after a transtibial or higher non-traumatic lower extremity amputation.

Authors:  Morten T Kristensen; Gitte Holm; Michael Krasheninnikoff; Pia S Jensen; Peter Gebuhr
Journal:  Acta Orthop       Date:  2016-04-18       Impact factor: 3.717

3.  Predictors of in-hospital mortality following major lower extremity amputations in type 2 diabetic patients using artificial neural networks.

Authors:  Ana Lopez-de-Andres; Valentin Hernandez-Barrera; Roberto Lopez; Pablo Martin-Junco; Isabel Jimenez-Trujillo; Alejandro Alvaro-Meca; Miguel Angel Salinero-Fort; Rodrigo Jimenez-Garcia
Journal:  BMC Med Res Methodol       Date:  2016-11-22       Impact factor: 4.615

4.  Mobility Analysis of AmpuTees II: Comorbidities and Mobility in Lower Limb Prosthesis Users.

Authors:  Shane R Wurdeman; Phillip M Stevens; James H Campbell
Journal:  Am J Phys Med Rehabil       Date:  2018-11       Impact factor: 2.159

5.  Risk of contralateral lower limb amputation and death after initial lower limb amputation - a population-based study.

Authors:  K Huseynova; R Sutradhar; G L Booth; A Huang; J G Ray
Journal:  Heliyon       Date:  2018-10-09

6.  Upper extremity distal dual bypass enables arteriovenous fistula construction in a critical limb ischemia.

Authors:  Tsukasa Nakamura; Kiyokazu Akioka; Shuji Nobori; Shumpei Harada; Norio Yoshimura; Hidetaka Ushigome
Journal:  J Surg Case Rep       Date:  2019-02-08

7.  One-Year Outcomes of Peripheral Endovascular Device Intervention in Critical Limb Ischemia Patients: Sub-Analysis of the LIBERTY 360 Study.

Authors:  Jihad A Mustapha; Zsuzsanna Igyarto; David O'Connor; Ehrin J Armstrong; Anthony R Iorio; Vickie R Driver; Fadi Saab; Ann N Behrens; Brad J Martinsen; George L Adams
Journal:  Vasc Health Risk Manag       Date:  2020-02-10

8.  Major lower extremity amputation: a contemporary analysis from an academic tertiary referral centre in a developing community.

Authors:  Qusai Aljarrah; Mohammed Z Allouh; Sohail Bakkar; Abdelwahab Aleshawi; Hasan Obeidat; Emad Hijazi; Nabil Al-Zoubi; Heba Alalem; Tagleb Mazahreh
Journal:  BMC Surg       Date:  2019-11-13       Impact factor: 2.102

9.  Topical "soft candle" applications for infected diabetic foot wounds: a cause for concern?

Authors:  Shamir O Cawich; Patrick Harnarayan; Shariful Islam; Bobb Nahmorah J; Steve Budhooram; Shivaa Ramsewak; Michael J Ramdass; Vijay Naraynsingh
Journal:  Int J Biomed Sci       Date:  2014-06

10.  Transtibial Osseointegration for Patients with Peripheral Vascular Disease: A Case Series of 6 Patients with Minimum 3-Year Follow-up.

Authors:  Muhammad Adeel Akhtar; Jason Shih Hoellwarth; Shakib Al-Jawazneh; William Lu; Claudia Roberts; Munjed Al Muderis
Journal:  JB JS Open Access       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.